Gabriel Byrne
Papers
3
Total Citations
26
H-Index
2
About
Gabriel Byrne is a bioprocess engineer and cell line development specialist whose work focuses on overcoming critical bottlenecks in HIV vaccine manufacturing. His research centers on the rapid and stable production of envelope glycoproteins (Envs) in Chinese Hamster Ovary (CHO) cell lines—a notoriously difficult task, as Env yields are typically 10–100 times lower than those of other pharmaceutical glycoproteins. Byrne’s most cited paper, “Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production” (2018, 21 citations), introduces an automated, high-throughput approach to accelerate the isolation of high-producing clones, directly addressing the yield challenge that has long hindered scalable vaccine production. In related work, he developed a stable MGAT1− CHO cell line capable of producing clade C gp120 with improved binding to broadly neutralizing antibodies, a critical step toward eliciting protective immune responses. By integrating robotics with cell engineering, Byrne’s contributions are helping to streamline the manufacture of complex HIV immunogens, moving the field closer to a viable vaccine. His work is particularly relevant for researchers in bioprocessing, glycoprotein engineering, and global health.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3